The Hydration Pharmaceuticals CoASX:HPC -20.00% Piotroski F-Score is 3 as of Jun. 26, 2026, which is at its 10-year median of 3.00. The stock has 3 warning signs investors should review. Among 298 Retail - Defensive companies, The Hydration Pharmaceuticals Co ranks worse than 84.9% on this metric.
Warning Sign:
Piotroski F-Score of 3 is low, which usually implies poor business operation.
The zones of discrimination were as such:
Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3
The Hydration Pharmaceuticals Co has an F-score of 3. It is a bad or low score, which usually implies poor business operation.
The historical rank and industry rank for The Hydration Pharmaceuticals Co's Piotroski F-Score or its related term are showing as below:
ASX:HPC'
s Piotroski F-Score Range Over the Past 10 Years
Min: 3 Med: 3 Max: 4
Current: 3
During the past 5 years, the highest Piotroski F-Score of The Hydration Pharmaceuticals Co was 4. The lowest was 3. And the median was 3.
The Hydration Pharmaceuticals Co (ASX:HPC) Piotroski F-Score Explanation
The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.
He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.
He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.
What he found was something that exceeded his most optimistic expectations.
Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.
Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).
Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.
The Hydration Pharmaceuticals Co Piotroski F-Score Related Terms
The Hydration Pharmaceuticals Co Piotroski F-Score Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The Hydration Pharmaceuticals Co Piotroski F-Score Chart
ASX:HPC vs SYY, USFD, PFGC: Piotroski F-Score Comparison
For the Food Distribution subindustry, The Hydration Pharmaceuticals Co's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
The Hydration Pharmaceuticals Co Piotroski F-Score vs Retail - Defensive Industry
For the Retail - Defensive industry and Consumer Defensive sector, The Hydration Pharmaceuticals Co's Piotroski F-Score distribution charts can be found below:
* The bar in red indicates where The Hydration Pharmaceuticals Co's Piotroski F-Score falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.
Profitability
Question 1. Return on Assets (ROA)
Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.
Score 1 if positive, 0 if negative.
The Hydration Pharmaceuticals Co's current Net Income (TTM) was -4.31.
==> Negative ==> Score 0.
Question 2. Cash Flow Return on Assets (CFROA)
Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.
Score 1 if positive, 0 if negative.
The Hydration Pharmaceuticals Co's current Cash Flow from Operations (TTM) was -5.50.
==> Negative ==> Score 0.
Question 3. Change in Return on Assets
Compare this year's return on assets (1) to last year's return on assets.
The Hydration Pharmaceuticals Co's return on assets of this year was -0.5458233. The Hydration Pharmaceuticals Co's return on assets of last year was 0.42146859.
==> Last year is higher ==> Score 0.
Question 4. Quality of Earnings (Accrual)
Compare Cash flow return on assets (2) to return on assets (1)
The Hydration Pharmaceuticals Co's gearing of this year was 0. The Hydration Pharmaceuticals Co's gearing of last year was 0.
==> This year is lower or equal to last year. ==> Score 1.
Question 6. Change in Working Capital (Liquidity)
Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.
Score 1 if this year's current ratio is higher, 0 if it's lower
The Hydration Pharmaceuticals Co's current ratio of this year was 2.83261803. The Hydration Pharmaceuticals Co's current ratio of last year was 2.23737947.
==> This year's current ratio is higher. ==> Score 1.
Question 7. Change in Shares in Issue
Compare the number of shares in issue this year, to the number in issue last year.
Score 0 if there is larger number of shares in issue this year, 1 otherwise.
The Hydration Pharmaceuticals Co's number of shares in issue this year was 387.201. The Hydration Pharmaceuticals Co's number of shares in issue last year was 290.678.
==> There is larger number of shares in issue this year. ==> Score 0.
Efficiency
Question 8. Change in Gross Margin
Compare this year's gross margin (Gross Profit divided by sales) to last year's.
Score 1 if this year's gross margin is higher, 0 if it's lower.
The Hydration Pharmaceuticals Co's gross margin of this year was 0.55188172. The Hydration Pharmaceuticals Co's gross margin of last year was 0.50582889.
==> This year's gross margin is higher. ==> Score 1.
Question 9. Change in asset turnover
Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.
Score 1 if this year's asset turnover ratio is higher, 0 if it's lower
The Hydration Pharmaceuticals Co's asset turnover of this year was 0.47154265. The Hydration Pharmaceuticals Co's asset turnover of last year was 0.50630252.
==> Last year's asset turnover is higher ==> Score 0.
Evaluation
Piotroski F-Score
=
Que. 1
+
Que. 2
+
Que. 3
+
Que. 4
+
Que. 5
+
Que. 6
+
Que. 7
+
Que. 8
+
Que. 9
=
0
+
0
+
0
+
0
+
1
+
1
+
0
+
1
+
0
=
3
Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3
The Hydration Pharmaceuticals Co has an F-score of 3. It is a bad or low score, which usually implies poor business operation.
The Hydration Pharmaceuticals Co (ASX:HPC) has a Piotroski F-Score of 3 as of Jun. 26, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on The Hydration Pharmaceuticals Co and its competitors. This is near median its historical median of 3.00. Over the past decade, The Hydration Pharmaceuticals Co's Piotroski F-Score has ranged from 3.00 to 4.00. According to the industry distribution chart, The Hydration Pharmaceuticals Co ranks #253 out of 298 companies in the Retail - Defensive industry, placing it in the top 84.9%.
Is The Hydration Pharmaceuticals Co's Piotroski F-Score too high?
The Hydration Pharmaceuticals Co's current Piotroski F-Score of 3 is near median its 10-year median of 3.00. Over the past 10 years, this metric has ranged from a low of 3.00 to a high of 4.00. The Retail - Defensive industry median Piotroski F-Score is 6.00. The Hydration Pharmaceuticals Co's value of 3 is 50% below this industry median. Based on the distribution chart, The Hydration Pharmaceuticals Co ranks #253 out of 298 companies in the Retail - Defensive industry, which is in the bottom quartile relative to peers.
How does The Hydration Pharmaceuticals Co's Piotroski F-Score compare to SYY and USFD?
According to the Retail - Defensive industry distribution chart, The Hydration Pharmaceuticals Co ranks #253 out of 298 companies for Piotroski F-Score. This places The Hydration Pharmaceuticals Co in the lower half of its industry. The industry median Piotroski F-Score is 6.00. The Hydration Pharmaceuticals Co's value of 3 is 50% below this benchmark. Historically, The Hydration Pharmaceuticals Co's own Piotroski F-Score has ranged from 3.00 to 4.00 over the past decade. While the company's 10-year median is 3.00 vs. the industry median of 6.00, The Hydration Pharmaceuticals Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Retail - Defensive company?
The median Piotroski F-Score among Retail - Defensive companies is 6.00, based on 298 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. The Hydration Pharmaceuticals Co's current Piotroski F-Score of 3 is 50% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on The Hydration Pharmaceuticals Co and its competitors. For the Retail - Defensive industry, the median Piotroski F-Score is 6.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. The Hydration Pharmaceuticals Co's current Piotroski F-Score is 3, which is near median its own 10-year median of 3.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Hydration Pharmaceuticals Co stock overvalued right now?
The Hydration Pharmaceuticals Co (ASX:HPC) has a current Piotroski F-Score of 3. The current Piotroski F-Score is 3, which is near median its 10-year median of 3.00 and 50% below the Retail - Defensive industry median of 6.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For The Hydration Pharmaceuticals Co (ASX:HPC), the current Piotroski F-Score is 3 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
The Hydration Pharmaceuticals Co Business Description
The Hydration Pharmaceuticals Co Ltd is a consumer products company that markets and sells a range of liquid, tablet and powder Healthy Hydration Solutions products into the USA market, under the Hydralyte brand. Hydralyte collates and translates consumer insights and needs into developing and delivering quality hydration products to market. The Company's business model is an asset light, flexible production model that allows it to outsource manufacturing and packaging to appropriate suppliers.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:HPC has been successfully added to your 